Protective effect of selenium-enriched lactobacillus on CCl4-induced liver injury in mice and its possible mechanisms

Figure 1 Change of MDA content in liver homogenates of mice with hepatic injury after Se-enriched lactobacillus treatment. ^aP < 0.05 vs model group; ^cP < 0.05 vs normal group.

Figure 2 Change of plasma TNF-α level in mice with hepatic injury after Se-enriched lactobacillus treatment. ^aP < 0.05 vsmodel group; ^cP < 0.05 vs normal group.

Figure 3 [Ca²⁺]i fluorescence visualizations (A) and intensities (B) in mice with hepatic injury after Se-enriched lactobacillus treatment. ^aP < 0.05 vs model group; ^cP < 0.05 vs normal group.